Literature DB >> 2522988

Carcinoid metastasis in the middle ear: anaesthetic and surgical management.

G J Bates1, F E Luscombe.   

Abstract

Mesh:

Substances:

Year:  1989        PMID: 2522988      PMCID: PMC1292049          DOI: 10.1177/014107688908200321

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  9 in total

1.  Carcinoid syndrome: its relevance to the anaesthetist.

Authors:  R A Mason; P A Steane
Journal:  Anaesthesia       Date:  1976-03       Impact factor: 6.955

2.  Argentaffin and argyrophil reactions and serotonin content of endocrine tumours.

Authors:  C A Wells; S M Taylor; A C Cuello
Journal:  J Clin Pathol       Date:  1985-01       Impact factor: 3.411

3.  Ketanserin: a selective antagonist of 5-HT2 serotoninergic receptors.

Authors:  J M Van Nueten; J E Leysen; J A Schuurkes; P M Vanhoutte
Journal:  Lancet       Date:  1983-02-05       Impact factor: 79.321

4.  Prophylactic use of ketanserin in a patient with carcinoid syndrome.

Authors:  M Fischler; M Dentan; M N Westerman; G Vourc'h; B Freitag
Journal:  Br J Anaesth       Date:  1983-09       Impact factor: 9.166

5.  A case of carcinoid tumor of the middle ear.

Authors:  R A Tange; J vd Borden; M E Schipper; W M Mooi
Journal:  J Laryngol Otol       Date:  1984-10       Impact factor: 1.469

6.  Primary carcinoid tumor of the ear.

Authors:  S Inoue; K Tanaka; S Kannae
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982-08

7.  Carcinoid tumors. An analysis of 2,837 cases.

Authors:  J D Godwin
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

8.  Carcinoid tumour of the middle ear associated with systemic symptoms.

Authors:  M A Latif; D J Madders; R P Barton; P A Shaw
Journal:  J Laryngol Otol       Date:  1987-05       Impact factor: 1.469

9.  Carcinoid tumor of the middle ear.

Authors:  G F Murphy; B Z Pilch; G R Dickersin; M L Goodman; J B Nadol
Journal:  Am J Clin Pathol       Date:  1980-06       Impact factor: 2.493

  9 in total
  1 in total

1.  [Neuroendocrine adenoma of the middle ear].

Authors:  S M Gut; B Wagner; M Kessler; T Linder
Journal:  HNO       Date:  2014-03       Impact factor: 1.284

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.